Editorial: is thalidomide a good option for patients with refractory Crohn's disease? Authors’ reply

E-ISSN： 1365-2036|41|8|786-786

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.41, Iss.8, 2015-04, pp. : 786-786

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: is thalidomide a good option for patients with refractory Crohn's disease?

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 8, 2015-04 ,pp. : 785-786

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term outcomes of thalidomide in refractory Crohn's disease

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 5, 2015-03 ,pp. : 429-437

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: stool adalimumab detection in ulcerative colitis and Crohn's disease – authors' reply

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 2, 2015-07 ,pp. : 241-241

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: betaretrovirus in biliary epithelia of patients with autoimmune and cryptogenic liver disease – authors’ reply

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 5, 2015-03 ,pp. : 491-491

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: novel association between serum Pentraxin‐2 levels and advanced fibrosis in well‐characterised patients with non‐alcoholic fatty liver disease – authors’ reply

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 6, 2015-09 ,pp. : 774-775

John Wiley & Sons Inc

Access to resources Recommend Favorite